AMRN Amarin Corp Plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMRN

Price (delayed)

$6.07

Market cap

$2.36B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$2.17B

Sector: Healthcare
Industry: Biotechnology
Website: http://www.amarincorp.com/

Highlights

AMRN's debt has dropped by 73% year-on-year and by 41% since the previous quarter
Amarin's gross profit has surged by 65% YoY and by 9% QoQ
The company's EPS has surged by 75% YoY but it fell by 25% QoQ
AMRN's net income has soared by 75% YoY but it is down by 27% from the previous quarter
AMRN's quick ratio is down by 36% year-on-year and by 9% since the previous quarter

Key stats

What are the main financial stats of AMRN
Market
Shares outstanding
388.83M
Market cap
$2.36B
Enterprise value
$2.17B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.89
Price to sales (P/S)
4.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.67
Earnings
Revenue
$590.09M
EBIT
-$12.67M
EBITDA
-$10.82M
Free cash flow
$7.03M
Per share
EPS
-$0.05
Free cash flow per share
$0.02
Book value per share
$1.56
Revenue per share
$1.51
TBVPS
$2.43
Balance sheet
Total assets
$960.2M
Total liabilities
$352.95M
Debt
$18.72M
Equity
$607.26M
Working capital
$562.36M
Liquidity
Debt to equity
0.03
Current ratio
2.72
Quick ratio
2.19
Net debt/EBITDA
17.79
Margins
EBITDA margin
-1.8%
Gross margin
78.4%
Net margin
-2.7%
Operating margin
-3.6%
Efficiency
Return on assets
-1.7%
Return on equity
-2.6%
Return on invested capital
-4.2%
Return on capital employed
-2%
Return on sales
-2.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMRN stock price

How has the Amarin stock price performed over time
Intraday
-0.98%
1 week
3.41%
1 month
15.18%
1 year
-68.71%
YTD
24.13%
QTD
24.13%

Financial performance

How have Amarin's revenue and profit performed over time
Revenue
$590.09M
Gross profit
$462.75M
Operating income
-$21.32M
Net income
-$15.86M
Gross margin
78.4%
Net margin
-2.7%
AMRN's net margin has surged by 84% year-on-year but it is down by 17% since the previous quarter
AMRN's operating margin has surged by 79% year-on-year but it is down by 2.9% since the previous quarter
AMRN's net income has soared by 75% YoY but it is down by 27% from the previous quarter
AMRN's operating income has soared by 65% year-on-year but it is down by 13% since the previous quarter

Growth

What is Amarin's growth rate over time

Valuation

What is Amarin stock price valuation
P/E
N/A
P/B
3.89
P/S
4.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.67
The company's EPS has surged by 75% YoY but it fell by 25% QoQ
AMRN's P/B is 31% below its last 4 quarters average of 5.6
The revenue has soared by 62% year-on-year and by 8% since the previous quarter
The P/S is 58% less than the 5-year quarterly average of 9.6 and 42% less than the last 4 quarters average of 6.9

Efficiency

How efficient is Amarin business performance
The ROIC has soared by 97% YoY and by 19% QoQ
AMRN's ROE has soared by 89% YoY but it is down by 24% from the previous quarter
The company's return on sales has surged by 87% YoY but it fell by 11% QoQ
Amarin's ROA has soared by 87% YoY but it has decreased by 21% from the previous quarter

Dividends

What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRN.

Financial health

How did Amarin financials performed over time
AMRN's total assets is 172% greater than its total liabilities
AMRN's quick ratio is down by 36% year-on-year and by 9% since the previous quarter
AMRN's total liabilities is up by 30% year-on-year and by 13% since the previous quarter
AMRN's debt is 97% smaller than its equity
Amarin's debt to equity has plunged by 75% YoY and by 40% from the previous quarter
AMRN's debt has dropped by 73% year-on-year and by 41% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.